Five Prime Therapeutics Reports Third Quarter 2020 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Five Prime Therapeutics (FPRX) Misses Q3 EPS by 14c
November 3, 2020 4:10 PM ESTFive Prime Therapeutics (NASDAQ: FPRX) reported Q3 EPS of ($0.74), $0.14 worse than the analyst estimate of ($0.60). Revenue for the quarter came in at $2.05 million versus the consensus estimate of $3.41 million.
For earnings history and earnings-related data on Five Prime Therapeutics (FPRX) click here.
... More